Steroidogenic activities in MA-10 Leydig cells are differentially altered by cAMP and Müllerian inhibiting substance.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Steroid Biochemistry and Molecular Biology

• Publication date

  2004-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.JSBMB.2004.07.002PMID 15555913
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Exposure of neonatal rats to diethylstilbestrol affects the expression of genes involved in ovarian differentiation.

  2003cited by this paper
• On the putative physiological role of allopregnanolone on GABA(A) receptor function.

  2003cited by this paper
• Roles of estrogen receptor alpha (ER alpha) in the regulation of the human Müllerian inhibitory substance (MIS) promoter.

  2003cited by this paper
• Protein Phosphatase 2A and Phosphoprotein SET Regulate Androgen Production by P450c17*

  2003cited by this paper
• Anti-Müllerian hormone and its role in ovarian function.

  2003cited by this paper
• 5alpha-androstane-3alpha,17beta-diol is formed in tammar wallaby pouch young testes by a pathway involving 5alpha-pregnane-3alpha,17alpha-diol-20-one as a key intermediate.

  2003cited by this paper
• 5α-androstane-3α, 17β-diol is formed in tammar wallaby pouch young testes by a pathway involving 5α-pregnane-3α, 17α-diol-20-one as a key intermediate

  2003cited by this paper
• Mullerian-inhibiting substance regulates NF–κB signaling in the prostate in vitro and in vivo

  2002cited by this paper
• Müllerian inhibiting substance blocks the protein kinase A-induced expression of cytochrome p450 17alpha-hydroxylase/C(17-20) lyase mRNA in a mouse Leydig cell line independent of cAMP responsive element binding protein phosphorylation.

  2002cited by this paper
• Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary.

  2002cited by this paper
• New approaches for high-yield purification of Müllerian inhibiting substance improve its bioactivity.

  2002cited by this paper
• Androgen biosynthesis from cholesterol to DHEA.

  2002cited by this paper
• Changes in Leydig Cell Gene Expression During Development in the Mouse1

  2002cited by this paper
• Increased expression of Müllerian-inhibiting substance correlates with inhibition of follicular growth in the developing ovary of rats treated with E2 benzoate.

  2002cited by this paper
• Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications.

  2001cited by this paper
• Müllerian Inhibiting Substance lowers testosterone in luteinizing hormone-stimulated rodents

  2001cited by this paper
• Implications of progesterone metabolism in MA-10 cells for accurate measurement of the rate of steroidogenesis.

  2001cited by this paper
• Müllerian Inhibiting Substance Inhibits Breast Cancer Cell Growth through an NFκB-mediated Pathway*

  2000cited by this paper
• Mullerian inhibiting substance inhibits breast cancer cell growth through an NFkappa B-mediated pathway.

  2000cited by this paper
• The inhibitory effects of allopregnanolone and pregnanolone on the population spike, evoked in the rat hippocampal CA1 stratum pyramidale in vitro, can be blocked selectively by epiallopregnanolone.

  2000cited by this paper
• Progesterone receptor is not required for progesterone action in the rat corpus luteum of pregnancy.

  1999cited by this paper
• Müllerian-inhibiting substance regulates androgen synthesis at the transcriptional level.

  1999cited by this paper
• Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.

  1999cited by this paper
• Müllerian-Inhibiting Substance Regulates Androgen Synthesis at the Transcriptional Level1.

  1999cited by this paper
• Control of Primordial Follicle Recruitment by Anti-Müllerian Hormone in the Mouse Ovary1.

  1999cited by this paper
• Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer*

  1998cited by this paper
• Kinetic analysis of successive reactions catalyzed by bovine cytochrome p450(17alpha,lyase).

  1998cited by this paper
• Effect of anti-Mullerian hormone on Sertoli and Leydig cell functions in fetal and immature rats.

  1998cited by this paper
• Receptors for anti-müllerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation.

  1998cited by this paper
• Fetal death in mice lacking 5α-reductase type 1 caused by estrogen excess

  1997cited by this paper
• Fetal death in mice lacking 5alpha-reductase type 1 caused by estrogen excess.

  1997cited by this paper
• 5 alpha-reduced androgens play a key role in murine parturition.

  1996cited by this paper
• Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation.

  1996cited by this paper
• Inhibition of androgen synthesis by 22‐hydroximino‐23,24‐bisnor‐4‐cholen‐3‐one

  1995cited by this paper
• Regulation of expression of steroidogenic enzymes in Leydig cells.

  1995cited by this paper
• Ontogeny of reproductive abnormalities induced by deregulation of anti-müllerian hormone expression in transgenic mice.

  1995cited by this paper
• Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome.

  1995cited by this paper
• Kinetic studies of cytochrome P-45017 alpha, lyase dependent androstenedione formation from progesterone.

  1995cited by this paper
• Müllerian-inhibiting substance function during mammalian sexual development.

  1994cited by this paper
• Steroid 5 alpha-reductase: two genes/two enzymes.

  1994cited by this paper
• Leydig cells: endocrine, paracrine, and autocrine regulation.

  1994cited by this paper
• Modeling and mutagenesis of the active site of human P450c17.

  1994cited by this paper
• Anti-müllerian hormone: the Jost factor.

  1993cited by this paper
• Anti-müllerian hormone: the Jost factor.

  1993cited by this paper
• Structural and biochemical properties of cloned and expressed human and rat steroid 5 alpha-reductases.

  1990cited by this paper
• Abnormal sexual development in transgenic mice chronically expressing Müllerian inhibiting substance

  1990cited by this paper
• Regulation of gonadotropin receptors and gonadotropin responses in a clonal strain of Leydig tumor cells by epidermal growth factor.

  1981cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• Identification of MEF2A, MEF2C, and MEF2D interactomes in basal and Fsk-stimulated mouse MA-10 Leydig cells.

  2025cites this paper
• Shared Pathophysiological Mechanisms and Genetic Factors in Early Menarche and Polycystic Ovary Syndrome

  2025cites this paper
• Mechanism of Action of an Environmentally Relevant Organochlorine Mixture in Repressing Steroid Hormone Biosynthesis in Leydig Cells

  2022cites this paper
• A 35-bp Conserved Region Is Crucial for Insl3 Promoter Activity in Mouse MA-10 Leydig Cells

  2022cites this paper
• The nuclear receptors SF1 and COUP-TFII cooperate on the Insl3 promoter in Leydig cells.

  2022cites this paper
• Functional Genetic Variation in the Anti-Müllerian Hormone Pathway in Women With Polycystic Ovary Syndrome.

  2019cites this paper
• The Nuclear Receptor COUP-TFII Regulates Amhr2 Gene Transcription via a GC-Rich Promoter Element in Mouse Leydig Cells

  2019cites this paper
• INVESTIGATING THE REPRODUCTIVE ROLE OF ANTI-MULLERIAN HORMONE VIA ANTI-MULLERIAN HORMONE RECEPTOR, TYPE II IN THE HEN

  2017cites this paper
• Insights into the Development of the Adult Leydig Cell Lineage from Stem Leydig Cells

  2017cites this paper
• Male Reproductive Disorders and Fertility Trends: Influences of Environment and Genetic Susceptibility.

  2016cites this paper
• MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA‐10 Leydig cells

  2016cites this paper
• Modèle in vitro pour l'étude de l'expression d'INSL3 en présence de perturbateurs endocriniens

  2016cites this paper
• Steroidogenesis in vitro : towards relevant models for endocrine disruptor screening

  2016cites this paper
• Crucial Genes and Pathways in Chicken Germ Stem Cell Differentiation

  2015cites this paper
• Notch signaling represses GATA4-induced expression of genes involved in steroid biosynthesis.

  2015cites this paper
• Myocyte enhancer factor 2 (MEF2) : un facteur impliqué dans le maintien des fonctions stéroïdogéniques des cellules de Leydig

  2015cites this paper
• Persistent Müllerian duct syndrome (PMDS) in the Polish free-ranged bull populations of the European bison (Bison bonasus L.).

  2015cites this paper
• Assessment of neuroprotective effects of gamma-hydroxybutyrate and neurosteroids on cellular models of Alzheimer’s disease

  2014cites this paper
• New reagents for detecting low antimüllerian hormone serum levels in perimenopausal women.

  2014cites this paper
• Sex differences in neurosteroid and hormonal responses to metyrapone in posttraumatic stress disorder

  2014cites this paper
• Male patients with terminal renal failure exhibit low serum levels of antimüllerian hormone

  2014cites this paper
• Endocrine disruptors differentially target ATP-binding cassette transporters in the blood-testis barrier and affect Leydig cell testosterone secretion in vitro.

  2013cites this paper
• Sex-specific expression of CTNNB1 in the gonadal morphogenesis of the chicken

  2013cites this paper
• Thyroid hormone and anti-Mullerian hormone (AMH) on Leydig cell differentiation: studies using C57BL/6 mice and AMH over expressing mice.

  2012cites this paper
• Dihydrolipoamide dehydrogenase and cAMP are associated with cadmium-mediated Leydig cell damage.

  2011cites this paper
• The chick embryo: an animal model for detection of the effects of hormonal compounds

  2007cites this paper
• Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance.

  2007cites this paper
• Diagnosis of 5α-Reductase Type 2 Deficiency: Contribution of Anti-Müllerian Hormone Evaluation

  2005cites this paper